Session Details
[27V01-pm]全合成③
Sat. Mar 27, 2021 1:15 PM - 2:39 PM JST
Sat. Mar 27, 2021 4:15 AM - 5:39 AM UTC
Sat. Mar 27, 2021 4:15 AM - 5:39 AM UTC
[Room V01] Oral Presentation 1 Online
座長:松尾 淳一(金沢大院医薬保)、伊藤 寛晃(東大院薬)
[27V01-pm01S]Asymmetric synthetic study of clavubicyclone
○Kazuki Enomoto1, Toyoharu Kobayashi1, Yuichiro Kawamoto1, Hisanaka Ito1 (1. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci.)
[27V01-pm02S]Synthetic study of nesteretal A
○Hideki Kitsukawa1, Yuichiro Kawamoto1, Toyoharu Kobayashi1, Hisanaka Ito1 (1. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci.)
[27V01-pm03S]Synthetic study of Kitungolide B
○Takaaki Furuhashi1, Toyoharu Kobayashi1, Yuichiro Kawamoto1, Hisanaka Ito1 (1. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci.)
[27V01-pm04S]Synthetic study of Callilongisin B
○Akinobu Kamiya1, Yuichiro Kawamoto1, Toyoharu Kobayashi1, Hisanaka Ito1 (1. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci.)
[27V01-pm05S]Synthetic study of Aurodox; type Ⅲ secretion system inhibitor
○Motoyoshi Ohara1, Akari Ikeda1,2, Asuka Nakajima1, Takanori Ōno1, Yoshihiko Noguchi1,2, Akito Watanabe1, Tomoyasu Hirose1,2, Toshiaki Sunazuka1,2 (1. Grad. Sch. of Infection Control Sci., Kitasato Univ., 2. Ōmura Inst., Kitasato Univ.)
[27V01-pm06S]Isolation and asymmetric total synthesis of Hymeglusins, the new circumventor of MEPM drug resistance
○Masahiro Kanaida1, Aoi Kimishima1,2, Shuhei Eguchi1, Masato Iwatsuki1,2, Kenichi Nonaka1,2, Hidehito Matsui1,2, Hideaki Hanaki1,2, Yukihiro Asami1,2, Tomoyasu Hirose1,2, Toshiaki Sunazuka1,2 (1. Grad. Sch. of Infection Control Sci., Kitasato Univ., 2. Ōmura Inst., Kitasato Univ.)
[27V01-pm07S]Total Synthesis of Luminamicin ;a potent anti anarobic bacterial activity
○Toru Kojima1, Hiroyasu Ando1, Aoi Kimishima1,2, Motoyoshi Ohara1, Yuki Inahashi1,2, Masato Iwatsuki1,2, Yoshihiro Watanabe2, Tomoyasu Hirose1,2, Toshiaki Sunazuka1,2 (1. Grad. Sch. Infection Control Sci., Kitasato Univ. , 2. Ōmura Inst. Kitasato Univ.)
